ARCHIVES

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

This article is from The Cancer Letter archive.

Vol. 32 No. 27 | July 14, 2006

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

January 20, 2006

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995

ACS Offers New Grants to Physicians

September 7, 1984

NAS Honors David Kessler; Satcher Seeks Obesity Plan.

January 12, 2001

Tobacco Use Research Centers Funded

October 22, 1999

Predicant, Correlogic executives contradict scientists’ claim that firms didn’t appear to compete.

June 25, 2004